Biologic medicines and immunotherapy are front and center amongst many of the R&D strategies and platforms for the industry’s leading developers.
Traditional channels remain the dominant form of HCP interaction in 13 major pharmaceutical markets, according to research by Cegedim Strategic Data. The company’s Global Promotion Audits showed varying levels of […]
There are at least 40,000 practicing hospitalists in the United States, and though these physicians are elusive, their ranks are growing By Kristin Scott, Society of Hospital Medicine […]
By Paul Shawah and Brian Longo Four years ago, IBM’s “Watson” supercomputer famously outplayed human competitors on the television game show, Jeopardy. Today, Watson’s power is derived from the cloud […]
Frost & Sullivan’s Life Sciences consultants have named seven developmental compounds as the most promising therapeutics to watch in 2015. Puma Biotechnology Inc.’s tyrosine kinase inhibitorneratinib, for extended adjuvant treatment […]
SalesandMarketing Measuring campaign ROI in the age of tapestry marketing By Chris Nelson Ever been to a brand campaign case study presentation at one of those big-name health care marketing […]
SALES›FORCE EFFECTIVENESS Pharma sales forces continue to evolve, trying to meet physicians’ information needs and survive in a healthcare environment radically altered by the Affordable Care Act ; and a […]
AGENDA 2015 The business of marketing pharmaceuticals today would be almost unrecognizable to a visitor from five years ago; the industry’s fate hangs on how industry leaders respond to all […]
The first month of the new year was a memorable one for Practice Fusion, a cloud-based electronic health record provider for doctors and patients, with one health management partnership showing […]
After asking industry leaders about all the issues we thought would matter most in 2015, we asked them what questions they thought we had missed. Here is what they told […]
